linagliptin

How long does Linagliptin stay in your body?

The elimination half-life of linagliptin is about 200 hours — the terminal (elimination) half-life at steady state, per the label — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. Read this number carefully: the label's headline terminal half-life is long only because of saturable binding to the target enzyme DPP-4, and the label explicitly says this prolonged elimination phase does NOT drive drug accumulation. The pharmacologically relevant figure for a once-daily drug is the effective (accumulation) half-life of about 11-12 hours; steady state is reached by the third dose with only ~1.3x accumulation. Plasma concentrations decline biphasically, so the ~200 h value is the terminal (beta) phase, not distribution. Not a prodrug. The one metabolite is pharmacologically INACTIVE (steady-state exposure ~13% of parent), so there is no active metabolite that outlasts the parent. Special populations: age, BMI, gender, and race have no clinically meaningful effect. Because linagliptin is ~90% excreted unchanged and only <5% renally, renal impairment (including severe) does not meaningfully change exposure and no dose adjustment is needed. Hepatic impairment (mild, moderate, or severe) gave comparable or slightly lower exposure — no clinically meaningful increase.

This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: Tradjenta (linagliptin) tablets — FDA label, DailyMed, §12.3 Pharmacokinetics, Elimination.

Frequently asked questions

What does Linagliptin treat?

Linagliptin (Linagliptin) may be used to treat type 2 diabetes mellitus, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How does Linagliptin work?

Linagliptin is a dipeptidyl peptidase 4 inhibitor. DPP-4 inhibitors block the enzyme that quickly destroys the body's own gut hormones (incretins like GLP-1). With these hormones lasting longer, the pancreas releases more insulin and less glucagon after meals, which lowers blood sugar.

Is there a coupon or discount for Linagliptin?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Linagliptin. To pay less, Linagliptin is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Linagliptin?

Linagliptin is marketed by Sunshine. You can see Sunshine's full profile, rating, and other products on pharmaranks.

Is Linagliptin a brand-name or generic drug?

Linagliptin is a generic medication; its active ingredient is Linagliptin. Generics contain the same active ingredient as the brand-name original and are usually lower cost.

Is Linagliptin available over the counter?

No. Linagliptin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Linagliptin come in?

Linagliptin is currently marketed as tablet, per the FDA's National Drug Code Directory.

What class of drug is Linagliptin?

Linagliptin is classified as dipeptidyl peptidase 4 inhibitor, per the FDA's Established Pharmacologic Class.

Is Linagliptin FDA-registered?

Linagliptin is on record with the U.S. FDA under application number ANDA208335. You can verify this on its official FDA label.